These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 7460040)

  • 21. [Unspecific immunological investigations in patients with malignant melanoma (author's transl)].
    Knopf B; Wätzig V
    Dermatol Monatsschr; 1982 Jan; 168(1):24-33. PubMed ID: 7044849
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experiences with immune BCG therapy of malignant melanoma].
    Altmeyer P; Nödl F
    Dtsch Med Wochenschr; 1978 Jul; 103(30):1214. PubMed ID: 668562
    [No Abstract]   [Full Text] [Related]  

  • 23. Local active immunotherapy for malignant melanoma.
    Serrou B; Dubois JB; Meiss L; Romieu C
    Panminerva Med; 1975; 17(5-6):182-6. PubMed ID: 1161316
    [No Abstract]   [Full Text] [Related]  

  • 24. [Intranodular treatment with BCG of cutaneous and subcutaneous metastases of malignant melanoma (author's transl)].
    Balzarini GP; Cascinelli N; Fontana V; Veronesi U
    Tumori; 1974; 60(4):345-52. PubMed ID: 4439501
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunologic reactions in malignant melanoma of the skin in man].
    Veresova OV; Korosteleva TA
    Vopr Onkol; 1975; 21(4):74-80. PubMed ID: 1105967
    [No Abstract]   [Full Text] [Related]  

  • 26. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
    Knopf B; Wätzig V; Knöll B
    Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunotherapy of malignant melanoma].
    Adler A
    Harefuah; 1986 Jul; 111(1-2):11-7. PubMed ID: 3781371
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
    Nathanson L; Clark DA
    Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
    [No Abstract]   [Full Text] [Related]  

  • 29. Mumps virus and BCG vaccine in metastatic melanoma.
    Minton JP
    Arch Surg; 1973 Apr; 106(4):503-6. PubMed ID: 4572347
    [No Abstract]   [Full Text] [Related]  

  • 30. Prognostic value of tuberculin and BCG immunoreactivity in stage I high-risk malignant melanoma (EORTC protocol 18781).
    Henz BM; Macher E; Bröcker EB; Suciu S; Steerenberg PA; Jung E; Rümke P
    Dermatology; 1996; 193(2):105-9. PubMed ID: 8884144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant therapy of malignant melanoma.
    Vosika GJ
    Minn Med; 1979 Jul; 62(7):515-7. PubMed ID: 386072
    [No Abstract]   [Full Text] [Related]  

  • 32. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
    Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
    J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
    [No Abstract]   [Full Text] [Related]  

  • 33. BCG in cancer therapy: theoretical bases of immunotherapy.
    Dodd MJ
    Am J Nurs; 1979 Feb; 79(2):310-4. PubMed ID: 311587
    [No Abstract]   [Full Text] [Related]  

  • 34. Intralesional BCG, intravenous immune lymphocytes, and immunization with neuraminidase-treated tumor cells to manage melanoma; A clinical assessment.
    Seigler HF; Shingleton WW; Pickrell KL
    Plast Reconstr Surg; 1975 Mar; 55(3):294-8. PubMed ID: 1118487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histologic changes in the human skin melanoma after intratumorous treatment with BCG.
    Svejda J; Mechl Z; Sopková B; Foukal T
    Neoplasma; 1979; 26(2):215-21. PubMed ID: 471128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cell-mediated BCG-diagnosis using a multipuncture apparatus in melanoma].
    Wolf M
    Dermatol Monatsschr; 1976 Sep; 162(9):756-7. PubMed ID: 992184
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunotherapy with BCG as coadjuvant in the management of malignant melanomas].
    Céspedes de Gómez MM; Aguilar Velázquez G; Valles de Cortés Y
    Alergia; 1980 Apr; 27(2):69-86. PubMed ID: 7416444
    [No Abstract]   [Full Text] [Related]  

  • 38. Does childhood vaccination and exposure to infection improve long-term survival in patients with malignant melanoma?
    Tarhini AA; Land S; Gupta A; Kirkwood JM
    Nat Clin Pract Oncol; 2005 May; 2(5):240-1. PubMed ID: 16264957
    [No Abstract]   [Full Text] [Related]  

  • 39. BCG stimulation of immune responsiveness in patients with malignant melanoma. Preliminary report.
    Gutterman J; Mavligit G; McBride C; Frei E; Hersh EM
    Cancer; 1973 Aug; 32(2):321-7. PubMed ID: 4722915
    [No Abstract]   [Full Text] [Related]  

  • 40. [Possibilities of an immunotherapy of malignant skin tumors with particular consideration of malignant melanomas (author's transl)].
    Schöpf E
    Ther Umsch; 1976 Aug; 33(8):538-42. PubMed ID: 1006610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.